RDHL ▼ -4.3% - RedHill Biopharma Ltd.
$RDHL RDHL RDHL - RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq®
RedHill Biopharma announced it is acquiring commercialization rights to Ferring's Rebyota® and Clenpiq® in what the company described as a transformational deal, though the stock fell 4.3% today, suggesting investors may have concerns about the acquisition terms, financing requirements, or integration challenges despite the strategic rationale of expanding the company's commercial portfolio.
01-SEP-2026 07:00 AM ET
Share this post
More filings for $RDHL
RDHL ▲ +8.3% - RedHill Biopharma Ltd.Nov 17, 2026RDHL ▲ +5.1% - RedHill Biopharma Ltd.Nov 2, 2026RDHL ▲ +4.2% - RedHill Biopharma Ltd.Oct 19, 2026RDHL ▼ -2.1% - RedHill Biopharma Ltd.Sep 30, 2026RDHL ▼ -2.2% - RedHill Biopharma Ltd.Sep 1, 2026RDHL ▼ -2.2% - RedHill Biopharma Ltd.Sep 1, 2026
View full $RDHL filing history →💬 Comments
Loading comments…
Leave a comment
